# Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers

> **NCT00231855** · PHASE2 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 31 (—)

## Conditions studied

- Ovarian Neoplasms
- Uterine Neoplasms

## Interventions

- **DRUG:** Topotecan and Taxotere

## Key facts

- **NCT ID:** NCT00231855
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 31 (—)
- **Last updated:** 2012-04-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231855, "Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00231855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*